EVRL – Red/Violet
Dual-Wavelength Versatility in a Handheld Platform
The EVRL combines 635nm red and 405nm violet wavelengths into a single non-thermal, precision handheld system. Designed for providers who want expanded clinical versatility, the EVRL supports musculoskeletal applications while also opening dermatological treatment pathways.
Two wavelengths. One streamlined device.
✔ Why Clinics Choose the EVRL
• Dual-wavelength technology (Red + Violet)
• Expanded protocol flexibility beyond red alone
• Portable handheld design
• Non-thermal visible laser delivery
• Supports both pain and dermatological applications
• FDA-cleared indications
See the Numbers for Your Practice.
Download the Laser ROI Calculator to project revenue impact, break-even timelines, and per-visit value increases based on your clinic volume.
Expand Beyond Red
The addition of violet wavelength expands clinical capability. While the red diode supports musculoskeletal indications, the violet diode introduces dermatological application opportunities, including acne treatment.
This makes the EVRL a strong crossover system for practices that treat both structural and skin-based conditions.
FDA Indications for Use (K152196)
The Erchonia® EVRL laser is generally indicated:
• Using the red diode: adjunctive use in providing temporary relief of minor chronic neck and shoulder pain of musculoskeletal origin
• Using the violet diode: to treat dermatological conditions, specifically moderate inflammatory Acne Vulgaris
Prescription Use (21 CFR 801 Subpart D). Intended for medical professionals.
How Dual Wavelengths Enhance Capability
Red wavelength has long served as the foundation of Erchonia pain therapy.
The addition of violet provides:
• Expanded protocol flexibility
• Broader patient application
• Clinical differentiation in competitive practices
All delivered through non-thermal visible light — without tissue heating.
Upgrade to Dual-Wavelength Precision
Expand your clinical capability without increasing complexity.